Pathologic and Oncologic Outcomes of Patients Undergoing Orchiectomy After Chemotherapy for Advanced Testicular Germ Cell Tumors

Pathologic and Oncologic Outcomes of Patients Undergoing Orchiectomy After Chemotherapy for Advanced Testicular Germ Cell Tumors

Background and objective: Delayed orchiectomy is generally recommended for patients who receive upfront chemotherapy for advanced testicular germ cell tumors (TGCTs). However, the risk of residual disease in the primary tumor and the relationship this has on oncologic outcomes are unclear. We aimed...

Full description

Saved in:
Bibliographic Details
Main Authors: Viranda H. Jayalath, Fady Baky, Samuel A. Gold, Nicole Liso, Brandon Williams, Samuel A. Funt, Darren R. Feldman, Victor E. Reuter, Joel Sheinfeld, Richard S. Matulewicz
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:European Urology Open Science
Subjects:
Chemotherapy
Germ cell tumor
Orchiectomy
Testicular cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168325002514
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items